PL-3994 Uses, Dosage, Side Effects and more
PL-3994 is under investigation in clinical trial NCT01304628 (Cross-Over Study of Subcutaneous Study Drug for the Treatment of Patients With Mild to Moderate Asthma).
| Trade Name | PL-3994 |
| Generic | PL-3994 |
| Type | |
| Formula | C82H127N27O20S2 |
| Weight | Average: 1875.21 Monoisotopic: 1873.919211945 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
